BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33069742)

  • 1. Hyaluronate siRNA nanoparticles with positive charge display rapid attachment to tumor endothelium and penetration into tumors.
    Luo J; Schmaus J; Cui M; Hörterer E; Wilk U; Höhn M; Däther M; Berger S; Benli-Hoppe T; Peng L; Wagner E
    J Control Release; 2021 Jan; 329():919-933. PubMed ID: 33069742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate receptor-directed orthogonal click-functionalization of siRNA lipopolyplexes for tumor cell killing in vivo.
    Klein PM; Kern S; Lee DJ; Schmaus J; Höhn M; Gorges J; Kazmaier U; Wagner E
    Biomaterials; 2018 Sep; 178():630-642. PubMed ID: 29580727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid.
    Chen CJ; Zhao ZX; Wang JC; Zhao EY; Gao LY; Zhou SF; Liu XY; Lu WL; Zhang Q
    Int J Nanomedicine; 2012; 7():3837-49. PubMed ID: 22888238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioreducible Cross-Linked Hyaluronic Acid/Calcium Phosphate Hybrid Nanoparticles for Specific Delivery of siRNA in Melanoma Tumor Therapy.
    Zhou Z; Li H; Wang K; Guo Q; Li C; Jiang H; Hu Y; Oupicky D; Sun M
    ACS Appl Mater Interfaces; 2017 May; 9(17):14576-14589. PubMed ID: 28393529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
    Choi KM; Jang M; Kim JH; Ahn HJ
    Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface coating of siRNA-peptidomimetic nano-self-assemblies with anionic lipid bilayers: enhanced gene silencing and reduced adverse effects in vitro.
    Zeng X; de Groot AM; Sijts AJ; Broere F; Oude Blenke E; Colombo S; van Eden W; Franzyk H; Nielsen HM; Foged C
    Nanoscale; 2015 Dec; 7(46):19687-98. PubMed ID: 26553270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.
    Liu Y; Song Z; Zheng N; Nagasaka K; Yin L; Cheng J
    Nanoscale; 2018 Aug; 10(32):15339-15349. PubMed ID: 30070662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery.
    Sun Q; Kang Z; Xue L; Shang Y; Su Z; Sun H; Ping Q; Mo R; Zhang C
    J Am Chem Soc; 2015 May; 137(18):6000-10. PubMed ID: 25869911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
    Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
    J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double Click-Functionalized siRNA Polyplexes for Gene Silencing in Epidermal Growth Factor Receptor-Positive Tumor Cells.
    Wang Y; Luo J; Truebenbach I; Reinhard S; Klein PM; Höhn M; Kern S; Morys S; Loy DM; Wagner E; Zhang W
    ACS Biomater Sci Eng; 2020 Feb; 6(2):1074-1089. PubMed ID: 33464867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
    Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
    ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bridge to silencing: Co-assembling anionic nanoparticles of siRNA and hyaluronan sulfate via calcium ion bridges.
    Forti E; Kryukov O; Elovic E; Goldshtein M; Korin E; Margolis G; Felder S; Ruvinov E; Cohen S
    J Control Release; 2016 Jun; 232():215-27. PubMed ID: 27117458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.
    Tirella A; Kloc-Muniak K; Good L; Ridden J; Ashford M; Puri S; Tirelli N
    Int J Pharm; 2019 Apr; 561():114-123. PubMed ID: 30822503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Click-Shielded and Targeted Lipopolyplexes.
    Klein PM; Wagner E
    Methods Mol Biol; 2019; 2036():141-164. PubMed ID: 31410795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-Targeting Anti-MicroRNA-155 Delivery Based on Biodegradable Poly(ester amine) and Hyaluronic Acid Shielding for Lung Cancer Therapy.
    Yang Y; Jia Y; Xiao Y; Hao Y; Zhang L; Chen X; He J; Zhao Y; Qian Z
    Chemphyschem; 2018 Aug; 19(16):2058-2069. PubMed ID: 29488305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
    Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
    J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.